Top

Published in:

Open Access 11-07-2022 | Type 2 Diabetes | Diabetes Epidemiology (H-C Yeh, Section Editor)

Content Validity of Patient-Reported Outcome Measures Developed for Assessing Health-Related Quality of Life in People with Type 2 Diabetes Mellitus: a Systematic Review

Authors: Caroline B. Terwee, Petra J. M. Elders, Marlous Langendoen-Gort, Ellen B. M. Elsman, Cecilia A. C. Prinsen, Amber A. van der Heijden, Maartje de Wit, Joline W. J. Beulens, Lidwine B. Mokkink, Femke Rutters

Published in: Current Diabetes Reports | Issue 9/2022

Abstract

Purpose of review

We aimed to systematically evaluate the content validity of patient-reported outcome measures (PROMs) specifically developed to measure (aspects of) health-related quality of life (HRQOL) in people with type 2 diabetes. A systematic review was performed in PubMed and Embase of PROMs measuring perceived symptoms, physical function, mental function, social function/participation, and general health perceptions, and that were validated to at least some extent. Content validity (relevance, comprehensiveness, and comprehensibility) was evaluated using COSMIN methodology.

Recent findings

We identified 54 (different versions of) PROMs, containing 150 subscales. We found evidence for sufficient content validity for only 41/150 (27%) (subscales of) PROMs. The quality of evidence was generally very low. We found 66 out of 150 (44%) (subscales of) PROMs with evidence for either insufficient relevance, insufficient comprehensiveness, or insufficient comprehensibility. For measuring diabetes-specific symptoms, physical function, mental function, social function/participation, and general health perceptions, we identified one to 11 (subscales of) PROMs with sufficient content validity, although quality of the evidence was generally low. For measuring depressive symptoms, no PROM with sufficient content validity was identified.

Summary

For each aspect of HRQL, we found at least one PROM with sufficient content validity, except for depressive symptoms. The quality of the evidence was mostly very low.

Available only for authorised users

Skovlund SE, Lichtenberg TH, Hessler D, Ejskjaer N. Can the routine use of patient-reported outcome measures improve the delivery of person-centered diabetes care? A review of recent developments and a case study. Curr DiabRep. 2019;19:84.

Langendoen-Gort M, Groeneveld L, Prinsen CAC, Beulens JW, Elders PJM, Halperin I, et al. Patient-reported outcome measures for assessing health-related quality of life in people with type 2 diabetes: a systematic review. Rev Endocr Metab Disord. in press.

Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39:2126–40.PubMedPubMedCentralCrossRef

ICHOM Diabetes in Adults Working Group. Type 1 and type 2

Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737–45.PubMedCrossRef

Terwee CB, Prinsen CAC, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27:1159–70.PubMedPubMedCentralCrossRef

U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009.

European Medical Agency. Reflection paper on the regulatory guidance for the use of health related quality of life (HRQL) measures in the evaluation of medicinal products. 2005.

El Achhab Y, Nejjari C, Chikri M, Lyoussi B. Disease-specific health-related quality of life instruments among adults diabetic: a systematic review. Diabetes Res Clin Pract. 2008;80:171–84.PubMedCrossRef

10.

Garratt AM, Schmidt L, Fitzpatrick R. Patient-assessed health outcome measures for diabetes: a structured review. Diabet Med: J British Diabet Assoc. 2002;19:1–11.CrossRef

11.

Luscombe FA. Health-related quality of life measurement in type 2 diabetes. Value Health. 2000;3(Suppl 1):15–28.PubMedCrossRef

12.

Roborel de Climens A, Tunceli K, Arnould B, Germain N, Iglay K, Norquist J, et al. Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy. Curr Med Res Opinion. 2015;31:643–65.CrossRef

13.

van Dijk SEM, Adriaanse MC, van der Zwaan L, Bosmans JE, van Marwijk HWJ, van Tulder MW, et al. Measurement properties of depression questionnaires in patients with diabetes: a systematic review. Qual Life Res. 2018;27:1415–30.PubMedPubMedCentralCrossRef

14.

Vieta A, Badia X, Sacristan JA. A systematic review of patient-reported and economic outcomes: value to stakeholders in the decision-making process in patients with type 2 diabetes mellitus. Clin Ther. 2011;33:1225–45.PubMedCrossRef

15.

Bottino LG, Madalosso MM, Garcia SP, Schaan BD, Teló GH. Diabetes-specific questionnaires validated in Brazilian Portuguese: a systematic review. Arch Endocrinol Metab. 2020;64:111–20.PubMed

16.

Hogg FR, Peach G, Price P, Thompson MM, Hinchliffe RJ. Measures of health-related quality of life in diabetes-related foot disease: a systematic review. Diabetologia. 2012;55:552–65.PubMedCrossRef

17.

Levterova BA, Dimitrova DD, Levterov GE, Dragova EA. Instruments for disease-specific quality-of-life measurement in patients with type 2 diabetes mellitus–a systematic review. Folia Med. 2013;55:83–92.CrossRef

18.

Ortega-Avila AB, Cervera-Garvi P, Ramos-Petersen L, Chicharro-Luna E, Gijon-Nogueron G. Patient-reported outcome measures for patients with diabetes mellitus associated with foot and ankle pathologies: a systematic review. J Clin Med. 2019;8:46.

19.

Gibbons E, Fitzpatrick R. A structured review of patient-reported outcome measures for people with diabetes: an update 2009. Oxford: University of Oxford, Department of Public Health, Patient-reported Outcome Measurement Group; 2009.

20.

Lee J, Lee EH, Kim CJ, Moon SH. Diabetes-related emotional distress instruments: a systematic review of measurement properties. Int J Nurs Stud. 2015;52:1868–78.PubMedCrossRef

21.

Chen YT, Tan YZ, Cheen M, Wee HL. Patient-reported outcome measures in registry-based studies of type 2 diabetes mellitus: a systematic review. Curr DiabRep. 2019;19:135.

22.

Wee PJL, Kwan YH, Loh DHF, Phang JK, Puar TH, Østbye T, et al. Measurement properties of patient-reported outcome measures for diabetes: systematic review. J Med Internet Res. 2021;23:e25002.PubMedPubMedCentralCrossRef

23.

Martin-Delgado J, Guilabert M, Mira-Solves J. Patient-reported experience and outcome measures in people living with diabetes: a scoping review of instruments. Patient. 2021;14:759–73.PubMedPubMedCentralCrossRef

24.

Pérez-Panero AJ, Ruiz-Muñoz M, Fernández-Torres R, Formosa C, Gatt A, Gónzalez-Sánchez M. Diabetic foot disease: a systematic literature review of patient-reported outcome measures. Qual Life Res. 2021;30:3395–405.PubMedCrossRef

25.

Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27:1147–57.PubMedPubMedCentralCrossRef

26.

Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27:1171–9.PubMedCrossRef

27.

Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–94.PubMedCrossRef

28.

Polonsky WH, Fisher L, Hessler D, Desai U, King SB, Perez-Nieves M. Toward a more comprehensive understanding of the emotional side of type 2 diabetes: a re-envisioning of the assessment of diabetes distress. J Diabetes Complications. 2022;36:108103.PubMedCrossRef

29.

Abetz L, Sutton M, Brady L, McNulty P, Gagnon DD. The diabetic foot ulcer scale (DFS): a quality of life instrument for use in clinical trials. Practical Diabetes Int. 2002;19:167–75.CrossRef

30.

Bann CM, Fehnel SE, Gagnon DD. Development and validation of the diabetic foot ulcer scale-short form (DFS-SF). Pharmacoeconomics. 2003;21:1277–90.PubMedCrossRef

31.

Garcia AA. The diabetes symptom self-care inventory: development and psychometric testing with Mexican Americans. J Pain Symptom Manage. 2011;41:715–27.PubMedPubMedCentralCrossRef

32.

Hayes RP, Nelson DR, Meldahl ML, Curtis BH. Ability to perform daily physical activities in individuals with type 2 diabetes and moderate obesity: a preliminary validation of the Impact of Weight on Activities of Daily Living Questionnaire. Diabetes Technol Ther. 2011;13:705–12.PubMedCrossRef

33.

Chuayruang K, Sriratanaban J, Hiransuthikul N, Suwanwalaikorn S. Development of an instrument for patient-reported outcomes in Thai patients with type 2 diabetes mellitus (PRO-DM-Thai). Asian Biomedicine. 2015;9:7–19.CrossRef

34.

Nagpal J, Kumar A, Kakar S, Bhartia A. The development of ’quality of life instrument for Indian diabetes patients (QOLID): a validation and reliability study in middle and higher income groups. J Assoc Physicians India. 2010;58:295–304.PubMed

35.

Svedbo Engstrom M, Leksell J, Johansson UB, Eeg-Olofsson K, Borg S, Palaszewski B, et al. A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register: development and evaluation of content validity, face validity, and test-retest reliability. Patient Educ Couns. 2018;101:139–46.PubMedCrossRef

36.

Leite WL, Huang IC, Marcoulides GA. Item selection for the development of short forms of scales using an ant colony optimization algorithm. Multivar Behav Res. 2008;43:411–31.CrossRef

37.

Elasy TA, Samuel-Hodge CD, DeVellis RF, Skelly AH, Ammerman AS, Keyserling TC. Development of a health status measure for older African-American women with type 2 diabetes. Diabetes Care. 2000;23:325–9.PubMedCrossRef

38.

Alavi NM, Ghofranipour F, Ahmadi F, Emami A. Developing a culturally valid and reliable quality of life questionnaire for diabetes mellitus. East Mediterr Health J. 2007;13:177–85.PubMed

39.

Hirsch A, Bartholomae C, Volmer T. Dimensions of quality of life in people with non-insulin-dependent diabetes. Qual Life Res. 2000;9:207–18.PubMedCrossRef

40.

Duran G, Herschbach P, Waadt S, Strian F, Zettler A. Assessing daily problems with diabetes: a subject-oriented approach to compliance. Psychol Rep. 1995;76:515–21.PubMedCrossRef

41.

Arbuckle RA, Humphrey L, Vardeva K, Arondekar B, Danten-Viala M, Scott JA, et al. Psychometric evaluation of the diabetes symptom checklist-revised (DSC-R)–a measure of symptom distress. Value Health. 2009;12:1168–75.PubMedCrossRef

42.

Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabet Med. 1994;11:253–61.PubMedCrossRef

43.

Shen W, Kotsanos JG, Huster WJ, Mathias SD, Andrejasich CM, Patrick DL. Development and validation of the diabetes quality of life clinical trial questionnaire. Med Care. 1999;37:AS45-66.PubMedCrossRef

44.

Pouwer F, Snoek FJ, van der Ploeg HM, Ader HJ, Heine RJ. The well-being questionnaire: evidence for a three-factor structure with 12 items (W-BQ12). Psychol Med. 2000;30:455–62.PubMedCrossRef

45.

Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28:626–31.PubMedCrossRef

46.

Thanakwang K, Thinganjana W, Konggumnerd R. Psychometric properties of the Thai version of the diabetes distress scale in diabetic seniors. Clin Interv Aging. 2014;9:1353–61.PubMedPubMedCentralCrossRef

47.

Batais MA, Alosaimi FD, AlYahya AA, Aloofi OA, Almashouq MK, Alshehri KS, et al. Translation, cultural adaptation, and evaluation of the psychometric properties of an Arabic diabetes distress scale: a cross sectional study from Saudi Arabia. Saudi Med J. 2021;42:509–16.PubMedPubMedCentralCrossRef

48.

Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18:754–60.PubMedCrossRef

49.

Bujang MA, Ismail M, Hatta N, Othman SH, Baharum N, Lazim SSM. Validation of the Malay version of diabetes quality of life (DQOL) questionnaire for adult population with type 2 diabetes mellitus. Malaysian J Med Sci: MJMS. 2017;24:86–96.CrossRef

50.

Cheng AY, Tsui EY, Hanley AJ, Zinman B. Developing a quality of life measure for Chinese patients with diabetes. Diabetes Res Clin Pract. 1999;46:259–67.PubMedCrossRef

51.

Cheng AY, Tsui EY, Hanley AJ, Zinman B. Cultural adaptation of the diabetes quality-of-life measure for Chinese patients. Diabetes Care. 1999;22:1216–7.PubMedCrossRef

52.

Hui LF, Yee-Tak Fong D, Yam M, Yuk IW. Translation and validation of the Chinese diabetic foot ulcer scale - short form. Patient. 2008;1:137–45.PubMedCrossRef

53.

Jacobson A, Barvsky I, Cleary P, Rand L. Reliability and validity of a diabetes quality-of life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care. 1988;11:725–32.

54.

Pakpour AH, Saffari M, Burri A. Translation and validation of an Iranian version of the diabetes quality of life measure. J Diabetes Investig. 2012;3:471–8.PubMedPubMedCentralCrossRef

55.

Sato F, Mita T, Yamamoto R, Hirose T, Ito C, Tamura Y, et al. Reliability and validity of the Japanese version of the diabetes quality-of-life questionnaire for Japanese patients with type 2 diabetes mellitus. Diabetol Int. 2014;5:21–9.CrossRef

56.

Yildirim A, Akinci F, Gozu H, Sargin H, Orbay E, Sargin M. Translation, cultural adaptation, cross-validation of the Turkish diabetes quality-of-life (DQOL) measure. Qual Life Res. 2007;16:873–9.PubMedCrossRef

57.

Al-Qerem W, Al-Maayah B, Ling J. Developing and validating the Arabic version of the diabetes quality of life questionnaire. East Mediterr Health J. 2021;27:414–26.PubMedCrossRef

58.

Boyer JG, Earp JA. The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39. Med Care. 1997;35:440–53.PubMedCrossRef

59.

Huang Y, Wu M, Xing P, Xie T, Cao Y, Qian P, et al. Translation and validation of the Chinese Cardiff wound impact schedule. Int J Low Extrem Wounds. 2014;13:5–11.PubMedCrossRef

60.

Rao PR, Shobhana R, Lavanya A, Padma C, Vijay V, Ramachandran A. Development of a reliable and valid psychosocial measure of self-perception of health in type 2 diabetes. J Assoc Physicians India. 2005;53:689–92.PubMed

61.

Kingsley C, Patel S. Patient-reported outcome measures and patient reported experience measures. BJA Education. 2017;17:137–44.CrossRef

62.

Harman NL, Wilding JPH, Curry D, Harris J, Logue J, Pemberton RJ, et al. Selecting Core Outcomes for randomised effectiveness trials in type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes. BMJ Open Diabetes Res Care. 2019;7:e000700.PubMedPubMedCentralCrossRef

63.

Nano J, Carinci F, Okunade O, Whittaker S, Walbaum M, Barnard-Kelly K, et al. A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach. Diabetic Med: J British Diabetic Assoc. 2020;37:2009–18.CrossRef

64.

Topp CW, Østergaard SD, Søndergaard S, Bech P. The WHO-5 well-being index: a systematic review of the literature. Psychother Psychosom. 2015;84:167–76.PubMedCrossRef

65.

Terwee CB, Zuidgeest M, Vonkeman HE, Cella D, Haverman L, Roorda LD. Common patient-reported outcomes across ICHOM Standard Sets – the value of PROMIS. BMC Med Inform Decis Mak 2021;21:259.

66.

Gangannagaripalli J, Albagli A, Myers SN, Whittaker S, Joseph A, Clarke A, et al. A standard set of value-based patient-centered outcomes and measures of overall health in adults. The Patient-Patient-Centered Outcomes Research. 2022;15(3):341–51.

67.

Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63:1179–94.PubMedPubMedCentralCrossRef

68.

Cappelleri JC, Jason Lundy J, Hays RD. Overview of classical test theory and item response theory for the quantitative assessment of items in developing patient-reported outcomes measures. Clin Ther. 2014;36:648–62.PubMedPubMedCentralCrossRef

69.

http://www.healthmeasures.net/promis.

70.

Scholle SH, Morton S, Homco J, Rodriguez K, Anderson D, Hahn E, et al. Implementation of the PROMIS-29 in routine care for people with diabetes: challenges and opportunities. J Ambul Care Manage. 2018;41:274–87.PubMedCrossRef

71.

McGuire BE, Morrison TG, Hermanns N, Skovlund S, Eldrup E, Gagliardino J, et al. Short-form measures of diabetes-related emotional distress: the problem areas in diabetes scale (PAID)-5 and PAID-1. Diabetologia. 2010;53:66–9.PubMedCrossRef

72.

Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273:59–65.PubMedCrossRef

73.

Terwee CB, Prinsen CAC, Chiarotto A, de Vet HCW, Bouter LM, Alonso J, et al. COSMIN methodology for assessing the content validity of PROMs. User manual version 1.0. www.cosmin.nl.

74.

Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.PubMedPubMedCentralCrossRef

75.

Hammond GS, Aoki TT. Measurement of health status in diabetic patients Diabetes Impact Measurement Scales. Diabetes Care. 1992;15:469–77.PubMedCrossRef

76.

Lee EH, Lee YW, Lee KW, Kim DJ, Kim SK. Development and psychometric evaluation of a diabetes-specific quality-of-life (D-QOL) scale. Diabetes Res Clin Pract. 2012;95:76–84.PubMedCrossRef

77.

Araki A, Ito H. Development of elderly diabetes burden scale for elderly patients with diabetes mellitus. Geriatr Gerontol Int. 2003;3:212–24.CrossRef

78.

Herschbach P, Duran G, Waadt S, Zettler A, Amm C, Marten-Mittag B. Psychometric properties of the questionnaire on stress in patients with diabetes–revised (QSD-R). Health Psychol: Off J Division Health Psychol Am Psychol Assoc. 1997;16:171–4.CrossRef

79.

Mannucci E, Ricca V, Bardini G, Rotella CM. Well-being enquiry for diabetics: a new measure of diabetes-related quality of life. Diabetes Nutr Metab-Clin Exp. 1996;9:89–102.

80.

Goh SG, Rusli BN, Khalid BA. Development and validation of the Asian diabetes quality of life (AsianDQOL) QUestionnaire. Diabetes Res Clin Pract. 2015;108:489–98.PubMedCrossRef

81.

Ting RZ, Nan H, Yu MW, Kong AP, Ma RC, Wong RY, et al. Diabetes-related distress and physical and psychological health in Chinese type 2 diabetic patients. Diabetes Care. 2011;34:1094–6.PubMedPubMedCentralCrossRef

82.

Fitzgerald JT, Davis WK, Connell CM, Hess GE, Funnell MM, Hiss RG. Development and validation of the diabetes care profile. Eval Health Prof. 1996;19:208–30.PubMedCrossRef

83.

Meadows KA, Abrams C, Sandbaek A. Adaptation of the diabetes health profile (DHP-1) for use with patients with Type 2 diabetes mellitus: psychometric evaluation and cross-cultural comparison. Diabet Med. 2000;17:572–80.PubMedCrossRef

84.

Kawata AK, Wilson H, Ong SH, Kulich K, Coyne K. Development and psychometric evaluation of the hypoglycemia perspectives questionnaire in patients with type 2 diabetes mellitus. Patient. 2016;9:395–407.PubMedCrossRef

85.

Hsu HC, Chang YH, Lee PJ, Chen SY, Hsieh CH, Lee YJ, et al. Developing and psychometric testing of a short-form problem areas in diabetes scale in Chinese patients. J Nursing Res: JNR. 2013;21:212–8.PubMedCrossRef

86.

Oobe M, Tanaka M, Fuchigami M, Sakata T. Preparation of a quality of life (QOL) questionnaire for patients with type II diabetes and prospects for its clinical application. Fukuoka Igaku Zasshi. 2007;98:379–87.PubMed

87.

Correr CJ, Pontarolo R, Melchiors AC, Rossignoli P, Fernandez-Llimos F. Radominski RB [Translation to Portuguese and validation of the diabetes quality of life measure (DQOL-Brazil)]. Arq Bras Endocrinol Metabol. 2008;52:515–22.PubMedCrossRef

88.

Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care. 1987;10:617–21.PubMedCrossRef

89.

Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet Med. 1990;7:445–51.PubMedCrossRef

90.

Sato E, Suzukamo Y, Miyashita M, Kazuma K. Development of a diabetes diet-related quality-of-life scale. Diabetes Care. 2004;27:1271–5.PubMedCrossRef

91.

Sato E, Ochiai R, Shibayama T, Nishigaki M, Abe Y, Sawa T, et al. Reliability and validity of revised and short form versions of diabetes diet-related quality of life scale. Diabetol Int. 2017;8:181–92.PubMedCrossRef

92.

Holmes-Truscott E, Skovlund SE, Hendrieckx C, Pouwer F, Peyrot M, Speight J. Assessing the perceived impact of diabetes on quality of life: psychometric validation of the DAWN2 impact of diabetes profile in the second diabetes MILES - Australia (MILES-2) survey. Diabetes Res Clin Pract. 2019;150:253–63.PubMedCrossRef

93.

Lin CY, Lee TY, Sun ZJ, Yang YC, Wu JS, Ou HT. Development of diabetes-specific quality of life module to be in conjunction with the World Health Organization quality of life scale brief version (WHOQOL-BREF). Health Qual Life Outcomes. 2017;15:167.PubMedPubMedCentralCrossRef

94.

Brasil F, Brasil AM, e Souza RA, Pontarolo R, Correr CJ. Development of the Brazilian brief version of the diabetes quality of life measure (DQOL-Brazil-8). Rev Bras Epidemiol. 2015;18:943–52.PubMedCrossRef

95.

Orozco-Beltran D, Artola S, Jansa M, Lopez de la Torre-Casares M, Fuster E. Impact of hypoglycemic episodes on health-related quality of life of type-2 diabetes mellitus patients: development and validation of a specific QoLHYPO((c)) questionnaire. Health Qual Life Outcomes. 2018;16:52.PubMedPubMedCentralCrossRef

96.

Mikhael E, Hassali M, Hussain S, Shawky N. The development and validation of quality of life scale for Iraqi patients with type 2 diabetes mellitus. J Pharm Bioallied Sci. 2020;12:262–8.PubMedPubMedCentralCrossRef

97.

Terwee CB, Jansma EP, Riphagen II, de Vet HC. Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res. 2009;18:1115–23.PubMedPubMedCentralCrossRef

98.

Peyrot M, Burns KK, Davies M, Forbes A, Hermanns N, Holt R, et al. Diabetes attitudes wishes and needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. Diabetes Res Clin Pract. 2013;99:174–84.PubMedCrossRef

99.

Choe MA, Padilla GV, Chae YR, Kim S. Quality of life for patients with diabetes in Korea–I: the meaning of health-related quality of life. Int J Nurs Stud. 2001;38:673–82.PubMedCrossRef

100.

Li J, Li Z, Zhao W, Pan H, Halloran EJ. The reliability and validity of the diabetes care profile for Chinese populations. Eval Health Prof. 2015;38:200–18.PubMedCrossRef

101.

Curcio R, Costa Alexandre NM, de Carvalho TH, Melo Lima MH. Translation and adaptation of the “Diabetes Distress Scale – DDS” in Brazilian culture. Acta Paul Enferm. 2012;25:762–7.CrossRef

102.

Farm BAS, Perwitasari DA, Thobari JA, Cao Q, Krabbe PFM, Postma MJ. Translation, revision, and validation of the diabetes distress scale for indonesian type 2 diabetic outpatients with various types of complications. Value Health Reg Issues. 2017;12:63–73.PubMedCrossRef

103.

Krzemińska S, Bąk E. Psychometric properties of the polish version of the diabetes distress scale (DDS). Psychol Res Behav Manag. 2021;14:1149–56.PubMedPubMedCentralCrossRef

104.

Benazizi I, Bernal-Soriano MC, Pardo Y, Ribera A, Peralta-Chiriboga A, Ferrer M, et al. Adaptation and psychometric validation of diabetes health profile (DHP-18) in patients with type 2 diabetes in Quito, Ecuador: a cross-sectional study. Health Qual Life Outcomes. 2021;19:189.PubMedPubMedCentralCrossRef

105.

Khader YS, Bataineh S, Batayha W. The Arabic version of Diabetes-39: psychometric properties and validation. Chronic Illn. 2008;4:257–63.PubMedCrossRef

106.

Nguyen TQ, Vo TQ, Nguyen GH, Nguyen TD. Assessment of health-related quality of life in patients with type II diabetes mellitus: a population-based study at a tertiary hospital. J Clin Diagn Res. 2018;12:LC44–51.

107.

Queiroz FA, Pace AE, Santos CB. Cross-cultural adaptation and validation of the instrument Diabetes - 39 (D-39): Brazilian version for type 2 diabetes mellitus patients - stage 1. Rev Lat Am Enfermagem. 2009;17:708–15.PubMedCrossRef

108.

Li TC, Lin CC, Liu CS, Li CI, Lee YD. Validation of the Chinese version of the diabetes impact measurement scales amongst people suffering from diabetes. Qual Life Res. 2006;15:1613–9.PubMedCrossRef

109.

Saffari M, Lin CY, O’Garo K, Koenig HG, Sanaeinasab H, Pakpour AH. Psychometric properties of Persian diabetes-mellitus specific quality of life (DMQoL) questionnaire in a population-based sample of Iranians. Int J Diabetes Dev Countries. 2019;39:218–27.CrossRef

110.

Huang IC, Hwang CC, Wu MY, Lin W, Leite W, Wu AW. Diabetes-specific or generic measures for health-related quality of life? Evidence from psychometric validation of the D-39 and SF-36. Value Health. 2008;11:450–61.PubMedCrossRef

111.

Diriba DC, Leung DYP, Suen LKP. Cultural adaptation and psychometric properties of the diabetes quality of life scale in Afaan Oromoo among people living with type 2 diabetes in Ethiopia. Int J Environ Res Public Health. 2021;18:7435.

112.

Lee EH, Lee YW, Lee KW, Kim YS, Nam MS. Measurement of diabetes-related emotional distress using the problem areas in diabetes scale: psychometric evaluations show that the short form is better than the full form. Health Qual Life Outcomes. 2014;12:142.PubMedPubMedCentralCrossRef

113.

Chin YW, Lai PS, Chia YC. The validity and reliability of the English version of the diabetes distress scale for type 2 diabetes patients in Malaysia. BMC Fam Pract. 2017;18:25.PubMedPubMedCentralCrossRef

Title: Content Validity of Patient-Reported Outcome Measures Developed for Assessing Health-Related Quality of Life in People with Type 2 Diabetes Mellitus: a Systematic Review
Authors: Caroline B. Terwee
Petra J. M. Elders
Marlous Langendoen-Gort
Ellen B. M. Elsman
Cecilia A. C. Prinsen
Amber A. van der Heijden
Maartje de Wit
Joline W. J. Beulens
Lidwine B. Mokkink
Femke Rutters
Publication date: 11-07-2022
Publisher: Springer US
Keyword: Type 2 Diabetes
Published in: Current Diabetes Reports / Issue 9/2022
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-022-01482-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Content Validity of Patient-Reported Outcome Measures Developed for Assessing Health-Related Quality of Life in People with Type 2 Diabetes Mellitus: a Systematic Review

Abstract

Purpose of review

Recent findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose of review

Recent findings

Summary

Please log in to get access to this content

Other articles of this Issue 9/2022

Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision

Electronic Health Record–Based Decision-Making Support in Inpatient Diabetes Management

Pharmacist Role in Providing Inpatient Diabetes Management

CGM in the Hospital: Is It Ready for Prime Time?

Risk of Type 2 Diabetes Among Individuals with Excess Weight: Weight Trajectory Effects

Lipodystrophy for the Diabetologist—What to Look For

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page